This is a standard initial ownership filing for a new insider. No trading signal or material event. Monitor for future Form 4 filings for any open-market transactions.
Price Chart
Executive Summary
Matthew Norkunas, M.D. filed a Form 3 initial statement of beneficial ownership with Obsidian Therapeutics, Inc., disclosing 30,937 shares of common stock and two stock option grants (180,000 shares at $0.78 expiring 2033-05-24, and 51,563 shares at $0.78 expiring 2034-06-24). This is a routine insider filing with no material financial impact.
Key Facts
- Matthew Norkunas filed a Form 3 initial statement of beneficial ownership.
- Disclosed 30,937 shares of common stock held directly.
- Disclosed two stock option grants: 180,000 shares at $0.78 expiring 2033-05-24, and 51,563 shares at $0.78 expiring 2034-06-24.
- Options vest in sixteen equal quarterly installments from June 30, 2023 and June 25, 2024, respectively.
- Filing includes a Power of Attorney authorizing multiple attorneys-in-fact to execute Section 16 filings.
Financial Impact
No financial impact; routine insider ownership disclosure.
Risk Factors
- No material risks identified from this filing.
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-330979 |
| Document: 0001193125-26-330979-index-headers.html | 0001193125-26-330979 |
| Document: 0001193125-26-330979-index.html | 0001193125-26-330979 |
| Document: 0001193125-26-330979.txt | 0001193125-26-330979 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 21d ago | SC 13G | $13.22 | awaiting T+20 | — | $13.60 (+2.84%) |
Sep 10, 2026 6w ago | EFFECT | $17.16 $12.24 | ▼ −28.67% | ▼ −30.80% | $13.60 (−20.78%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $13.60 (−60.01%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $13.60 (−60.01%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $13.60 (−60.01%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $13.60 (−60.01%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $13.60 (−60.01%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $13.60 (−60.01%) |
Aug 3, 2026 12w ago | 8-K | $34.00 $17.04 | ▲ +49.88% | ▲ +48.64% | $13.60 (+60.01%) |
Jul 6, 2026 16w ago | EFFECT | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers